PRESS RELEASE published on 03/13/2024 at 08:05, 2 years 4 months ago BioNxt Reports Successful Results From ODF Cladribine PK Study BioNxt Solutions Inc. announces successful completion of comparative pharmacokinetic study for its oral dissolvable film Cladribine product for Multiple Sclerosis treatment, demonstrating rapid absorption similar to reference drug BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery System
PRESS RELEASE published on 02/17/2024 at 01:50, 2 years 5 months ago BioNxt Solutions Finalizes Agreement BioNxt Solutions Inc. finalizes Settlement Agreement with a creditor to settle $282,415 debt through issuance of common shares and a cash payment. Debt to be settled in three instalments of shares based on market price Common Shares Debt Settlement BioNxt Solutions Inc. Settlement Agreement Creditor
PRESS RELEASE published on 01/30/2024 at 05:48, 2 years 6 months ago BIONXT SOLUTIONS ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising gross proceeds of $288,000 to fund drug development and working capital purposes Private Placement Working Capital Investment Drug Development BioNxt Solutions Inc.
PRESS RELEASE published on 12/22/2023 at 09:05, 2 years 7 months ago BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE published on 12/22/2023 at 01:50, 2 years 7 months ago BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
PRESS RELEASE published on 12/12/2023 at 09:05, 2 years 7 months ago BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
PRESS RELEASE published on 12/09/2023 at 04:30, 2 years 7 months ago BioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s Warrants
PRESS RELEASE published on 11/25/2023 at 01:44, 2 years 8 months ago Bionxt Solutions Announces Convertible Debenture and Interest Settlement
PRESS RELEASE published on 11/20/2023 at 09:05, 2 years 8 months ago BioNxt Accelerates Cladribine ODF Clinical and Commercialization Strategy for Multiple Sclerosis Treament
PRESS RELEASE published on 11/15/2023 at 15:10, 2 years 8 months ago BioNxt berichtet über das Entwicklungs- und Vermarktungsprogramm zu seinem neuen Produkt Cladribine ODF
Published on 08/04/2026 at 17:00, 2 hours 13 minutes ago Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
Published on 08/04/2026 at 16:25, 2 hours 48 minutes ago ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 4 hours 13 minutes ago Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah
Published on 08/04/2026 at 15:00, 4 hours 13 minutes ago Secure Blockchain's Agentic Solutions Signs First Enterprise AI Customer
Published on 08/04/2026 at 14:30, 4 hours 43 minutes ago Agassi Sports Entertainment Launches Global "Let's Play" Pickleball and Padel Platform Initiative
Published on 08/04/2026 at 18:25, 48 minutes ago Amendment to the Prospectus of the Company and the Key Information Documents of the SubFunds
Published on 08/04/2026 at 18:00, 1 hour 13 minutes ago 2CRSi SA: Quanthor et 2CRSi s’associent pour sécuriser les infrastructures critiques à l’ère post-quantique
Published on 08/04/2026 at 18:00, 1 hour 13 minutes ago 2CRSi SA: Quanthor and 2CRSi join forces to secure critical infrastructure in the post-quantum era
Published on 08/04/2026 at 17:40, 1 hour 33 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
Published on 08/04/2026 at 18:32, 41 minutes ago Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 1 hour 28 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 08/04/2026 at 17:45, 1 hour 28 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/04/2026 at 17:35, 1 hour 38 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
